Controlled Delivery Systems: From Pharmaceuticals to Cells and Genes
暂无分享,去创建一个
Rui L. Reis | Elizabeth Rosado Balmayor | H. S. Azevedo | R. Reis | E. Balmayor | Helena Sepulveda Azevedo | H. Azevedo
[1] R. Reis,et al. Preparation and characterization of starch-poly-epsilon-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications. , 2009, Acta biomaterialia.
[2] Marilena Loizidou,et al. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. , 2009, Trends in pharmacological sciences.
[3] Gorka Orive,et al. History, challenges and perspectives of cell microencapsulation. , 2004, Trends in biotechnology.
[4] Lisa Brannon-Peppas,et al. Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.
[5] Jörg A Auer,et al. Localized insulin-like growth factor I delivery to enhance new bone formation. , 2003, Bone.
[6] R. Langer,et al. Effects of low-frequency ultrasound on the transdermal permeation of mannitol: comparative studies with in vivo and in vitro skin. , 2002, Journal of pharmaceutical sciences.
[7] R L Reis,et al. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts) , 2008, Journal of tissue engineering and regenerative medicine.
[8] E. Lavelle,et al. Delivery systems and adjuvants for oral vaccines , 2006, Expert opinion on drug delivery.
[9] Schipper,et al. Cyclodextrins in nasal drug delivery. , 1999, Advanced drug delivery reviews.
[10] S. Sakai,et al. Development of alginate–agarose subsieve-size capsules for subsequent modification with a polyelectrolyte complex membrane , 2006 .
[11] J. Susset,et al. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group. , 1999, The Journal of urology.
[12] J. Huard,et al. Muscle-derived stem cells for tissue engineering and regenerative therapy. , 2007, Biomaterials.
[13] Iqbal,et al. Starch capsules: an alternative system for oral drug delivery. , 2000, Pharmaceutical science & technology today.
[14] K. Johnston,et al. Templated Open Flocs of Nanorods for Enhanced Pulmonary Delivery with Pressurized Metered Dose Inhalers , 2008, Pharmaceutical Research.
[15] T. Abribat,et al. The rise and rise of drug delivery , 2005, Nature Reviews Drug Discovery.
[16] Gordana Vunjak-Novakovic,et al. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. , 2007, Biomaterials.
[17] Gorka Orive,et al. Delivering growth factors for therapeutics. , 2008, Trends in pharmacological sciences.
[18] C. Pinilla,et al. Targeting approaches to oral drug delivery , 2002, Expert opinion on biological therapy.
[19] J. Thipphawong,et al. Safety and pharmacokinetics of inhaled morphine delivered using the AERx system in patients with moderate-to-severe asthma. , 2004, International journal of clinical pharmacology and therapeutics.
[20] Samir Mitragotri,et al. Micro-scale devices for transdermal drug delivery. , 2008, International journal of pharmaceutics.
[21] A. Kanai,et al. Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors. , 2001, Molecular urology.
[22] X. Wu,et al. Temperature and pH-responsive polymeric composite membranes for controlled delivery of proteins and peptides. , 2004, Biomaterials.
[23] Ludovico Cademartiri,et al. Nanofabrication by self-assembly , 2009 .
[24] Lorenz Meinel,et al. Silk fibroin spheres as a platform for controlled drug delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[25] Baolin Guo,et al. Preparation and properties of a pH/temperature-responsive carboxymethyl chitosan/poly(N-isopropylacrylamide)semi-IPN hydrogel for oral delivery of drugs. , 2007, Carbohydrate research.
[26] G. Bernstein. Delivery of insulin to the buccal mucosa utilizing the RapidMist™ system , 2008 .
[27] D. Mooney,et al. Hydrogels for tissue engineering. , 2001, Chemical reviews.
[28] Po‐Chang Chiang,et al. Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies. , 2008, Journal of pharmaceutical sciences.
[29] R. Langer,et al. Designing materials for biology and medicine , 2004, Nature.
[30] Cheryl H. Dean,et al. Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates , 2005, Human vaccines.
[31] A. Berkowitz,et al. Novel Drug Delivery Systems: Future Directions , 2009, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.
[32] Gabriela A Silva,et al. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. , 2007, Advanced drug delivery reviews.
[33] S. Sakai,et al. Production of cell‐enclosing hollow‐core agarose microcapsules via jetting in water‐immiscible liquid paraffin and formation of embryoid body‐like spherical tissues from mouse ES cells enclosed within these microcapsules , 2008, Biotechnology and bioengineering.
[34] Gorka Orive,et al. Techniques: new approaches to the delivery of biopharmaceuticals. , 2004, Trends in pharmacological sciences.
[35] Robert Langer,et al. Advances in Biomaterials, Drug Delivery, and Bionanotechnology , 2003 .
[36] L. Babiuk,et al. Microparticles for oral delivery of vaccines , 2005, Expert opinion on drug delivery.
[37] D J Mooney,et al. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis , 2007, Journal of thrombosis and haemostasis : JTH.
[38] K. Balos,et al. Encapsulation and osteoinduction of human periodontal ligament fibroblasts in chitosan-hydroxyapatite microspheres. , 2007, Journal of biomedical materials research. Part A.
[39] G. Liversidge,et al. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs , 1995 .
[40] Takuro Niidome,et al. PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[41] Mark R Prausnitz,et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans , 2008, Proceedings of the National Academy of Sciences.
[42] Mark G. Allen,et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] M. Brewster,et al. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.
[44] A. Okyar,et al. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes , 2010, Drug development and industrial pharmacy.
[45] Vladimir P Torchilin,et al. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. , 2006, Annual review of biomedical engineering.
[46] Anil Kumar Bajpai,et al. Responsive polymers in controlled drug delivery , 2008 .
[47] Javad Parvizi,et al. Selfprotective smart orthopedic implants , 2007, Expert review of medical devices.
[48] P. Brunetti,et al. Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. , 2006, Transplantation proceedings.
[49] D. Mooney,et al. Transplanted Endothelial Cells Enhance Orthotopic Bone Regeneration , 2006, Journal of dental research.
[50] M. Elmazar,et al. Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs. , 2002, International journal of pharmaceutics.
[51] P. Shah. Use of Nanotechnologies for Drug Delivery , 2006 .
[52] J. Huard,et al. Muscle-based gene therapy and tissue engineering for the musculoskeletal system. , 2001, Drug discovery today.
[53] Freddie H. Fu,et al. Gene therapy and the future of cartilage repair , 2001 .
[54] G. Orive,et al. Cell microencapsulation technology for biomedical purposes: novel insights and challenges. , 2003, Trends in pharmacological sciences.
[55] S. Sakai,et al. Agarose–gelatin conjugate for adherent cell-enclosing capsules , 2007, Biotechnology Letters.
[56] M. Alaoui-Ismaili,et al. Design of second generation therapeutic recombinant bone morphogenetic proteins. , 2009, Cytokine & growth factor reviews.
[57] You Han Bae,et al. Polymer Architecture and Drug Delivery , 2006, Pharmaceutical Research.
[58] E. Cevher,et al. Nasal Delivery of High Molecular Weight Drugs , 2009, Molecules.
[59] G. Lust,et al. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. , 2002, The Journal of bone and joint surgery. British volume.
[60] Antonios G Mikos,et al. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[61] U Conte,et al. Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility. , 1996, Biomaterials.
[62] M. Ferrari,et al. Drug Delivery Systems , 2006 .
[63] David L Kaplan,et al. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. , 2006, Biomaterials.
[64] H. Maibach,et al. Percutaneous Penetration Enhancers: An Overview , 2007, Skin Pharmacology and Physiology.
[65] T. Gill,et al. Effects of auricular chondrocyte expansion on neocartilage formation in photocrosslinked hyaluronic acid networks. , 2006, Tissue engineering.
[66] D. Kohane,et al. HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES , 2008 .
[67] Yasuhiko Tabata,et al. Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture. , 2006, Biomaterials.
[68] S. Davis,et al. Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal Women , 2005, Journal of clinical pharmacology.
[69] Wijaya Martanto,et al. Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.
[70] Gorka Orive,et al. Drug delivery in biotechnology: present and future. , 2003, Current opinion in biotechnology.
[71] S. Feng,et al. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. , 2006, Biomaterials.
[72] P. Laurent,et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. , 2007, Vaccine.
[73] K Remberger,et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I) , 2005, Gene Therapy.
[74] Henry,et al. Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.
[75] S. Lyu,et al. A novel method of encapsulating and cultivating adherent mammalian cells within collagen microcarriers , 2007, Biotechnology and bioengineering.
[76] R. Reis,et al. Drug delivery therapies I General trends and its importance on bone tissue engineering applications , 2002 .
[77] A. Shrivastava,et al. Development and Characterization of Mucoadhesive Microspheres Bearing Salbutamol for Nasal Delivery , 2004, Drug delivery.
[78] J. Hadgraft,et al. Modified-Release Drug Delivery Technology , 2002 .
[79] Giovanni Luca,et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. , 2006, Diabetes care.
[80] Freddie H. Fu,et al. Gene therapy and tissue engineering for sports medicine , 2003, The journal of gene medicine.
[81] Implants in Drug Delivery , 2011 .
[82] G. Liversidge,et al. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats , 1995 .
[83] S. Scheindlin. Transdermal drug delivery: PAST, PRESENT, FUTURE. , 2004, Molecular interventions.
[84] Cesario Z. Cerna,et al. Effect of Nanonization on Absorption of 301029: Ex Vivo and In Vivo Pharmacokinetic Correlations Determined by Liquid Chromatography/Mass Spectrometry , 2002, Pharmaceutical Research.
[85] P. Zambelli,et al. Orthopedic implant used as drug delivery system: clinical situation and state of the research. , 2008, Current Drug Delivery.
[86] Philippe Rogueda. Novel hydrofluoroalkane suspension formulations for respiratory drug delivery , 2005, Expert opinion on drug delivery.
[87] David J. Mooney,et al. Spatio–temporal VEGF and PDGF Delivery Patterns Blood Vessel Formation and Maturation , 2007, Pharmaceutical Research.
[88] S. Mitragotri,et al. Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.
[89] Gorka Orive,et al. Cell microencapsulation technology: towards clinical application. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[90] S. Waldman,et al. The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy Volunteers , 2004, Journal of clinical pharmacology.
[91] Barrett E. Rabinow,et al. Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.
[92] M. Cormier,et al. Transdermal Delivery of Antisense Oligonucleotides with Microprojection Patch (macroflux®) Technology , 2001, Pharmaceutical Research.
[93] M. Allen,et al. Microfabricated microneedles for gene and drug delivery. , 2000, Annual review of biomedical engineering.
[94] R. Hayes,et al. Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes* , 2007, Current medical research and opinion.
[95] V V Ranade,et al. Drug Delivery Systems 4. Implants in Drug Delivery , 1990, Journal of clinical pharmacology.
[96] T. Chang,et al. Therapeutic applications of polymeric artificial cells , 2005, Nature Reviews Drug Discovery.
[97] E. Schwarz,et al. Review: gene- and stem cell-based therapeutics for bone regeneration and repair. , 2007, Tissue engineering.
[98] L. R. Kaiser. The future of multihospital systems. , 1992, Topics in health care financing.
[99] I. Quijada-Garrido,et al. A novel controlled drug delivery system based on pH-responsive hydrogels included in soft gelatin capsules. , 2010, Acta biomaterialia.
[100] K. Jain. Strategies and technologies for drug delivery systems , 1998 .
[101] P. Vos,et al. Advances and Barriers in Mammalian Cell Encapsulation for Treatment of Diabetes , 2006 .
[102] U. Banakar,et al. Implantable Drug Delivery , 1994, Journal of biomaterials applications.
[103] Robert Langer,et al. Transdermal drug delivery , 2008, Nature Biotechnology.
[104] E. Versi,et al. Dry Mouth With Conventional and Controlled‐Release Oxybutynin in Urinary Incontinence , 2000, Obstetrics and gynecology.
[105] M. Sangalli,et al. Oral pulsatile drug delivery systems , 2005, Expert opinion on drug delivery.
[106] Adrian C. Williams,et al. Penetration enhancers. , 2004, Advanced drug delivery reviews.
[107] J. Huard,et al. Gene therapy strategies for urological dysfunction. , 2001, Trends in molecular medicine.
[108] Paolo Colombo,et al. Multi-layered hydrophilic matrices as constant release devices (GeomatrixTM Systems) , 1993 .
[109] Carol Tucker-Burden,et al. Immune responses to an encapsulated allogeneic islet beta-cell line in diabetic NOD mice. , 2006, Biochemical and biophysical research communications.
[110] R. Reis,et al. Drug delivery therapies II. Strategies for delivering bone regenerating factors , 2002 .
[111] R. Duncan. The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.
[112] Vladimir R Muzykantov,et al. Polymeric carriers: role of geometry in drug delivery. , 2008, Expert opinion on drug delivery.
[113] M. Cormier,et al. Macroflux Technology for Transdermal Delivery of Therapeutic Proteins and Vaccines , 2002 .
[114] Denis Dufrane,et al. Six-Month Survival of Microencapsulated Pig Islets and Alginate Biocompatibility in Primates: Proof of Concept , 2006, Transplantation.
[115] S. Chan,et al. Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. , 2002, Journal of pharmaceutical sciences.
[116] P. Robbins,et al. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy , 2005, Gene Therapy.
[117] M. Hatziapostolou,et al. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[118] Antonios G Mikos,et al. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. , 2008, Bone.
[119] J. Swanson,et al. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. , 2003, Archives of general psychiatry.
[120] K. Boekelheide,et al. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys , 2006, Neurobiology of Disease.
[121] C. Rhodes,et al. Coatings for controlled-release drug delivery systems. , 1998, Drug development and industrial pharmacy.
[122] R. Tuan,et al. Concepts in gene therapy for cartilage repair. , 2008, Injury.
[123] Gorka Orive,et al. Encapsulated cell technology: from research to market. , 2002, Trends in biotechnology.
[124] Thomas H. LaBean,et al. Nanofabrication by DNA self-assembly , 2009 .
[125] Teerapol Srichana,et al. Development of a pH-responsive drug delivery system for enantioselective-controlled delivery of racemic drugs. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[126] M. Allen,et al. Lack of Pain Associated with Microfabricated Microneedles , 2001, Anesthesia and analgesia.
[127] N. Peppas,et al. Bioadhesives for optimization of drug delivery. , 1995, Journal of drug targeting.
[128] Yi Hong,et al. Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation. , 2007, Acta biomaterialia.
[129] S. Werner,et al. Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.
[130] M. Machluf,et al. Alginate–chitosan complex coacervation for cell encapsulation: Effect on mechanical properties and on long‐term viability , 2006, Biopolymers.
[131] Kaiser Lr. The future of multihospital systems. , 1992 .
[132] Y. Tabata,et al. Non-viral gene transfection technologies for genetic engineering of stem cells. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[133] Johnny Huard,et al. The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine. , 2002, Trends in cardiovascular medicine.